Covidien completes enrollment on ev3 atherectomy device study | Research roundup April 11, 2011 By MassDevice staff Leave a Comment Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year.